These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10828710)

  • 1. Use of chlorhexidine-releasing nylon fibres to reduce device-related uterine infections.
    Gard PR; Reynolds JP; Hanlon GW
    Gynecol Obstet Invest; 2000; 49(4):261-5. PubMed ID: 10828710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and teratogenicity of chlorhexidine diacetate released from hollow nylon fibres.
    Ostad SN; Gard PR
    J Pharm Pharmacol; 2000 Jul; 52(7):779-84. PubMed ID: 10933128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of transcervical monofilament insertion on the microbial status of the uterus in guinea-pigs.
    Bilbruck J; Hanlon GW; Gard PR; Martin GP
    J Pharm Pharmacol; 1994 Mar; 46(3):213-6. PubMed ID: 8027930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrauterine devices].
    Delavest P; Engelmann P
    Rev Prat; 1980 Dec; 30(57):3981-2, 3985-7. PubMed ID: 7455547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine contamination in the guinea pig following transcervical uterine monofilament insertion.
    Gard PR; Malhi JS; Hanlon GW
    Gynecol Obstet Invest; 1993; 35(1):49-52. PubMed ID: 8449434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chlorhexidine-coated intrauterine device on the bacteriology of the uterine cavity.
    Jackson R; Newton JR; Emens MJ; Burdon DW; Dieben TO
    Adv Contracept; 1991 Mar; 7(1):55-65. PubMed ID: 1872197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing infection related to insertion of an intrauterine device.
    Jovanovic R; Barone CM; Van Natta FC; Congema E
    J Reprod Med; 1988 Apr; 33(4):347-52. PubMed ID: 3367334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological colonisation of uterine cavity: role of tailed intrauterine contraceptive device.
    Sparks RA; Purrier BG; Watt PJ; Elstein M
    Br Med J (Clin Res Ed); 1981 Apr; 282(6271):1189-91. PubMed ID: 6788128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine contraception.
    Rao RP; Scommegna A
    Am Fam Physician; 1977 Nov; 16(5):177-85. PubMed ID: 920572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection hazards and complications following the use of IUDs].
    Böhm W; Seewald HJ; Voigt R; Süss C
    Zentralbl Gynakol; 1977; 99(24):1484-8. PubMed ID: 605704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the intrauterine contraceptive device with and without an extracervical appendage or tail.
    Buchman MI
    Fertil Steril; 1970 Apr; 21(4):348-55. PubMed ID: 5508502
    [No Abstract]   [Full Text] [Related]  

  • 15. [IUD and gynecological infections].
    Marino L; Montoli S; Beretta P; Riccardi A; Sciarra E; Di Battista G
    Minerva Ginecol; 1987; 39(1-2):47-55. PubMed ID: 3574747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing.
    Karpanen TJ; Casey AL; Conway BR; Lambert PA; Elliott TS
    J Antimicrob Chemother; 2011 Aug; 66(8):1777-84. PubMed ID: 21609979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intrauterine device in the present and future.
    Rivera R; Chi IC; Farr G
    Curr Opin Obstet Gynecol; 1993 Dec; 5(6):829-32. PubMed ID: 8286697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic effects of intrauterine devices.
    Corfman PA; Segal SJ
    Am J Obstet Gynecol; 1968 Feb; 100(3):448-59. PubMed ID: 15782465
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and use-effectiveness of intrauterine devices.
    Kaye BM; Reaney BV; Kaye DL; Edelman DA
    Fertil Steril; 1977 Sep; 28(9):937-42. PubMed ID: 892045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.